Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
Brandes
David W
DW
Hope MS Center, Knocville, TN 37934, USA. dwbnorth@sbcglobal.net
D000700:Analgesics / Q000627:therapeutic use*; D006801:Humans; D007194:India; D008942:Mitoxantrone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000700:Analgesics; D008942:Mitoxantrone